日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways

新型小分子酪氨酸激酶2假激酶配体阻断细胞因子诱导的TYK2介导的信号通路

Yu Zhou ,Xin Li ,Ru Shen ,Xiangzhu Wang ,Fan Zhang ,Suxing Liu ,Di Li ,Jian Liu ,Puhui Li ,Yinfa Yan ,Ping Dong ,Zhigao Zhang ,Heping Wu ,Linghang Zhuang ,Rasheduzzaman Chowdhury ,Matthew Miller ,Mena Issa ,Yuchang Mao ,Hongli Chen ,Jun Feng ,Jing Li ,Chang Bai ,Feng He ,Weikang Tao

SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis

SHR1032 是一种新型 STING 激动剂,可刺激抗肿瘤免疫并直接诱导 AML 细胞凋亡

Chunying Song #, Dong Liu #, Suxing Liu, Di Li, Ivana Horecny, Xinzhu Zhang, Puhui Li, Lei Chen, Matthew Miller, Rasheduzzaman Chowdhury, Mena Issa, Ru Shen, Yinfa Yan, Fengqi Zhang, Lei Zhang, Limin Zhang, Chang Bai, Jun Feng, Linghang Zhuang, Rumin Zhang, Jing Li, Hilary Wilkinson, Jian Liu, Weika

Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis

发现一种新型 RORγ 拮抗剂,可通过皮肤限制暴露来局部治疗轻度至中度牛皮癣

Suxing Liu #, Dong Liu #, Ru Shen, Di Li, Qiyue Hu, Yinfa Yan, Jiakang Sun, Fengqi Zhang, Hong Wan, Ping Dong, Jun Feng, Rumin Zhang, Jing Li, Lianshan Zhang, Weikang Tao

A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast Cancer

新型 CD73 抑制剂 SHR170008 可抑制肿瘤中的腺苷,并通过 PD-1 阻断增强乳腺癌小鼠模型中的抗肿瘤活性

Suxing Liu, Di Li, Jian Liu, Huiyun Wang, Ivana Horecny, Ru Shen, Rumin Zhang, Heping Wu, Qiyue Hu, Peng Zhao, Fengqi Zhang, Yinfa Yan, Jun Feng, Linghang Zhuang, Jing Li, Lianshan Zhang, Weikang Tao